Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Open-Label Extension Study of 23mg Donepezil SR in Patients With Moderate to Severe Alzheimer's Disease
This study is not yet open for participant recruitment.
Study NCT00566501.   Last updated on November 29, 2007.
Information provided by Eisai Medical Research Inc.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00566501
Contacts
Contact: Eisai Medical Services 1-888-422-4743

Locations
United States, California
Apex Research Institute
Santa Ana, California, United States, 92705
Sponsors and Collaborators
Eisai Medical Research Inc.
Investigators
Study Director: Margaret Moline, Ph.D Eisai Medical Research Inc.




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services